Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Trasplante de células madre alogénicas versus tratamiento convencional para el linfoma de linfocitos T cutáneo primario avanzado

Información

DOI:
https://doi.org/10.1002/14651858.CD008908.pub3Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 29 agosto 2013see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Hematología

Copyright:
  1. Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Max Schlaaka

    Correspondencia a: Department of Dermatology and Venerology, University Hospital of Cologne, Cologne, Germany

    [email protected]

    authors have contributed equally (first author)

  • Juliane Pickenhaina

    Department of Dermatology and Venerology, University Hospital of Cologne, Cologne, Germany

    authors have contributed equally (first author)

  • Sebastian Theuricha

    Department I of Internal Medicine, Stem Cell Transplantation Program, University Hospital of Cologne, Cologne, Germany

    authors have contributed equally (first author)

  • Nicole Skoetz

    Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

  • Michael von Bergwelt‐Baildona

    Department I of Internal Medicine, Stem Cell Transplantation Program, University Hospital of Cologne, Cologne, Germany

    authors have contributed equally (last author)

  • Peter Kurschata

    Department of Dermatology and Venerology, University Hospital of Cologne, Cologne, Germany

    authors have contributed equally (last author)

Contributions of authors

Authors Max Schlaak, Juliane Pickenhain and Sebastian Theurich have contributed equally to the review and mainly developed the protocol. Nicole Skoetz has reviewed and structured the drafting of the review by Cochrane guidelines. Michael von Bergwelt‐Baildon and Peter Kurschat reviewed and supervised the clinical and scientific questions of the review.

Sources of support

Internal sources

  • Skin Cancer Center, Germany.

    Universityhospital of Cologne
    Department of Dermatology and Venerology

External sources

  • No sources of support supplied

Declarations of interest

For participation in scientific meetings Peter Kurschat was supported by Roche and Cephalon. None declared for other authors.

Acknowledgements

The authors wish to thank the following members of the Haematological Malignancies Group: Ina Monsef (Trial Search Co‐ordinator), Prof. Ben Djulbegovic (Content Editor), Dr. Sue Richards (Statistic Editor) and Sabine Kluge (Managing Editor) for their support and comments. Many thanks to Dr. Jos Verbeek (Cochrane Non‐Randomised Studies Methods Group) for additionally commenting on this review.

Version history

Published

Title

Stage

Authors

Version

2013 Aug 29

Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma

Review

Max Schlaak, Juliane Pickenhain, Sebastian Theurich, Nicole Skoetz, Michael von Bergwelt‐Baildon, Peter Kurschat

https://doi.org/10.1002/14651858.CD008908.pub3

2012 Jan 18

Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma

Review

Max Schlaak, Juliane Pickenhain, Sebastian Theurich, Nicole Skoetz, Michael von Bergwelt‐Baildon, Peter Kurschat

https://doi.org/10.1002/14651858.CD008908.pub2

2010 Dec 08

Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T cell lymphoma

Protocol

Max Schlaak, Sebastian Theurich, Nicole Skoetz, Juliane Pickenhain, Andreas Engert, Peter Kurschat, Michael Bergwelt‐Baildon

https://doi.org/10.1002/14651858.CD008908

Differences between protocol and review

None.

Keywords

MeSH

Medical Subject Headings Check Words

Humans;

Update 2013
Figuras y tablas -
Figure 1

Update 2013